# Prestige Consumer Healthcare Inc. (PBH)

Source: https://www.quantisnow.com/company/PBH
Generated: 2026-11-10T21:27:58.239Z

- Ticker: PBH
- Exchange: NYSE
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2005
- SEC CIK: 0001295947
- Website: prestigebrands.com

## About

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

## Latest PBH news and filings

- 2026-11-05 11:09 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Prestige Consumer Healthcare Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-prestige-consumer-healthcare-inc-6774137)
- 2026-11-05 11:02 UTC [SEC Form 8-K] [Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-filed-sec-form-8-k-results-of-6774096)
- 2026-11-05 11:00 UTC [Earnings] [Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-reports-fiscal-2027-second-quarter-results-6773965)
- 2026-10-14 12:30 UTC [Earnings Date] [Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results](https://www.quantisnow.com/insight/prestige-consumer-healthcare-to-release-fiscal-2027-second-quarter-earnings-6746003)
- 2026-09-30 13:18 UTC [More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds](https://www.quantisnow.com/insight/more-than-half-of-us-women-have-avoided-talking-about-6730269)
- 2026-09-08 21:00 UTC [Conference Announcement] [Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-to-participate-in-barclays-global-consumer-6708621)
- 2026-08-10 21:00 UTC [Conference Announcement] [Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-to-participate-in-canaccord-genuity-annual-6674203)
- 2026-08-06 10:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Prestige Consumer Healthcare Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-prestige-consumer-healthcare-inc-6666877)
- 2026-08-06 10:04 UTC [SEC Form 8-K] [Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-filed-sec-form-8-k-results-of-6666828)
- 2026-08-06 10:00 UTC [Earnings Date] [Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-reports-fiscal-2027-first-quarter-results-6666744)
- 2026-08-05 20:08 UTC [SEC Form 4] [Director Zier Dawn M. was granted 2,981 shares, increasing direct ownership by 18% to 19,514 units (SEC Form 4)](https://www.quantisnow.com/insight/director-zier-dawn-m-was-granted-2981-shares-increasing-direct-6665230)
- 2026-08-05 20:08 UTC [SEC Form 4] [Director Kelly John F. was granted 2,981 shares, increasing direct ownership by 61% to 7,832 units (SEC Form 4)](https://www.quantisnow.com/insight/director-kelly-john-f-was-granted-2981-shares-increasing-direct-6665206)
- 2026-08-05 20:07 UTC [SEC Form 4] [Director Darecca James was granted 2,981 shares, increasing direct ownership by 45% to 9,572 units (SEC Form 4)](https://www.quantisnow.com/insight/director-darecca-james-was-granted-2981-shares-increasing-direct-ownership-6665188)
- 2026-08-05 20:06 UTC [SEC Form 4] [Director Byom John E was granted 2,981 shares, increasing direct ownership by 6% to 54,575 units (SEC Form 4)](https://www.quantisnow.com/insight/director-byom-john-e-was-granted-2981-shares-increasing-direct-6665150)
- 2026-08-05 20:07 UTC [SEC Form 4] [Director Clark Celeste A. was granted 2,981 shares, increasing direct ownership by 22% to 16,511 units (SEC Form 4)](https://www.quantisnow.com/insight/director-clark-celeste-a-was-granted-2981-shares-increasing-direct-6665138)
- 2026-07-15 20:03 UTC [SEC Form 8-K] [Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-filed-sec-form-8-k-entry-into-6638196)
- 2026-07-09 20:43 UTC [SEC Form 8-K] [Amendment: Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-prestige-consumer-healthcare-inc-filed-sec-form-8-k-financial-6633254)
- 2026-07-07 14:48 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Prestige Consumer Healthcare Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-prestige-consumer-healthcare-6629830)
- 2026-07-06 12:05 UTC [SEC Form 8-K] [Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-filed-sec-form-8-k-entry-into-6627360)
- 2026-07-06 12:00 UTC [Earnings Date] [Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-completes-acquisition-of-lacorium-health-prices-6627319)
- 2026-06-30 12:24 UTC [Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-announces-offering-of-400-million-senior-6620076)
- 2026-06-30 10:01 UTC [SEC Form 8-K] [Amendment: Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-prestige-consumer-healthcare-inc-filed-sec-form-8-k-financial-6619819)
- 2026-06-29 10:06 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Prestige Consumer Healthcare Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-prestige-consumer-healthcare-inc-6618087)
- 2026-06-16 10:15 UTC [SEC Form 8-K] [Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-filed-sec-form-8-k-entry-into-6603758)
- 2026-06-15 13:00 UTC [Prestige Consumer Healthcare Inc Completes Acquisition of Breathe Right®](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-completes-acquisition-of-breathe-right-6602061)
- 2026-06-05 12:44 UTC [Conference Announcement] [Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-to-participate-in-the-oppenheimer-annual-6590657)
- 2026-05-14 20:32 UTC [SEC Form 10-K] [SEC Form 10-K filed by Prestige Consumer Healthcare Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-prestige-consumer-healthcare-inc-6554467)
- 2026-05-14 20:01 UTC [SEC Form 4] [Amendment: CFO & COO Sacco Christine covered exercise/tax liability with 1,091 shares, decreasing direct ownership by 2% to 57,374 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-cfo-coo-sacco-christine-covered-exercisetax-liability-with-1091-6553555)
- 2026-05-14 12:50 UTC [Analyst Downgrade] [Prestige Consumer downgraded by Oppenheimer](https://www.quantisnow.com/insight/prestige-consumer-downgraded-by-oppenheimer-6552729)
- 2026-05-13 20:35 UTC [SEC Form 8-K] [Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-filed-sec-form-8-k-entry-into-6551351)
- 2026-05-13 20:30 UTC [Earnings Date] [Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium Health](https://www.quantisnow.com/insight/prestige-consumer-healthcare-inc-reports-fiscal-2026-results-announces-acquisition-6551219)
- 2026-05-12 20:01 UTC [SEC Form 4] [Senior VP Operations Zerillo Jeffrey sold $18,350 worth of shares (351 units at $52.28), decreasing direct ownership by 0.83% to 41,810 units (SEC Form 4)](https://www.quantisnow.com/insight/senior-vp-operations-zerillo-jeffrey-sold-18350-worth-of-shares-6547767)
- 2026-05-11 20:03 UTC [SEC Form 4] [Senior VP Operations Zerillo Jeffrey sold $16,580 worth of shares (305 units at $54.36) and covered exercise/tax liability with 351 shares, decreasing direct ownership by 2% to 42,161 units (SEC Form 4)](https://www.quantisnow.com/insight/senior-vp-operations-zerillo-jeffrey-sold-16580-worth-of-shares-6544679)
- 2026-05-11 20:02 UTC [SEC Form 4] [CFO & COO Sacco Christine covered exercise/tax liability with 991 shares, decreasing direct ownership by 1% to 71,636 units (SEC Form 4)](https://www.quantisnow.com/insight/cfo-coo-sacco-christine-covered-exercisetax-liability-with-991-shares-6544673)
- 2026-05-11 20:01 UTC [SEC Form 4] [Chief Executive Officer Lombardi Ronald M. covered exercise/tax liability with 2,543 shares, decreasing direct ownership by 0.68% to 373,465 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-lombardi-ronald-m-covered-exercisetax-liability-with-6544656)
- 2026-05-11 20:00 UTC [SEC Form 4] [EVP, Marketing & Sales Mekhail Adel covered exercise/tax liability with 487 shares, decreasing direct ownership by 2% to 25,703 units (SEC Form 4)](https://www.quantisnow.com/insight/evp-marketing-sales-mekhail-adel-covered-exercisetax-liability-with-487-6544623)
- 2026-05-07 20:02 UTC [SEC Form 4] [Senior VP Operations Zerillo Jeffrey covered exercise/tax liability with 307 shares and sold $66,373 worth of shares (1,207 units at $54.99), decreasing direct ownership by 3% to 42,820 units (SEC Form 4)](https://www.quantisnow.com/insight/senior-vp-operations-zerillo-jeffrey-covered-exercisetax-liability-with-307-6538675)
- 2026-05-07 20:01 UTC [SEC Form 4] [CFO & COO Sacco Christine covered exercise/tax liability with 1,267 shares, decreasing direct ownership by 2% to 72,627 units (SEC Form 4)](https://www.quantisnow.com/insight/cfo-coo-sacco-christine-covered-exercisetax-liability-with-1267-shares-6538665)
- 2026-05-07 20:01 UTC [SEC Form 4] [Chief Executive Officer Lombardi Ronald M. covered exercise/tax liability with 2,197 shares, decreasing direct ownership by 0.58% to 376,008 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-lombardi-ronald-m-covered-exercisetax-liability-with-6538622)
- 2026-05-06 21:17 UTC [SEC Form 4] [CFO & COO Sacco Christine was granted 18,984 shares and covered exercise/tax liability with 3,434 shares, increasing direct ownership by 27% to 73,894 units (SEC Form 4)](https://www.quantisnow.com/insight/cfo-coo-sacco-christine-was-granted-18984-shares-and-covered-6536424)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PBH
- Earnings history: https://www.quantisnow.com/earnings/PBH
- Dividend history: https://www.quantisnow.com/dividends/PBH
- Insider transactions: https://www.quantisnow.com/insiders/PBH
- Options chain: https://www.quantisnow.com/options/PBH
- SEC 8-K filings only: https://www.quantisnow.com/company/PBH/8-k
- RSS and alerts for PBH: https://www.quantisnow.com/docs/rss-feeds.md